JP2023517566A5 - - Google Patents

Info

Publication number
JP2023517566A5
JP2023517566A5 JP2022554288A JP2022554288A JP2023517566A5 JP 2023517566 A5 JP2023517566 A5 JP 2023517566A5 JP 2022554288 A JP2022554288 A JP 2022554288A JP 2022554288 A JP2022554288 A JP 2022554288A JP 2023517566 A5 JP2023517566 A5 JP 2023517566A5
Authority
JP
Japan
Prior art keywords
tetrafluoro
trifluoromethylbenzylamino
composition
use according
benzoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022554288A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023517566A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000136 external-priority patent/WO2021181159A1/en
Publication of JP2023517566A publication Critical patent/JP2023517566A/ja
Publication of JP2023517566A5 publication Critical patent/JP2023517566A5/ja
Pending legal-status Critical Current

Links

JP2022554288A 2020-03-11 2021-03-10 再開通療法後の再灌流傷害又は出血を処置するための組成物及び方法 Pending JP2023517566A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062988187P 2020-03-11 2020-03-11
US62/988,187 2020-03-11
PCT/IB2021/000136 WO2021181159A1 (en) 2020-03-11 2021-03-10 Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy

Publications (2)

Publication Number Publication Date
JP2023517566A JP2023517566A (ja) 2023-04-26
JP2023517566A5 true JP2023517566A5 (https=) 2024-03-19

Family

ID=77665492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554288A Pending JP2023517566A (ja) 2020-03-11 2021-03-10 再開通療法後の再灌流傷害又は出血を処置するための組成物及び方法

Country Status (12)

Country Link
US (3) US11826329B2 (https=)
EP (1) EP4117648A4 (https=)
JP (1) JP2023517566A (https=)
KR (1) KR20230010187A (https=)
CN (1) CN115515573A (https=)
AU (1) AU2021233206A1 (https=)
BR (1) BR112022018136A2 (https=)
CA (1) CA3174709A1 (https=)
CO (1) CO2022014343A2 (https=)
IL (2) IL309923A (https=)
MX (2) MX2022011214A (https=)
WO (1) WO2021181159A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12285182B2 (en) 2018-10-10 2025-04-29 Innova Vascular, Inc. Devices and methods for removing an embolus
CN115515573A (zh) 2020-03-11 2022-12-23 Gnt制药有限公司 用于治疗再通疗法之后再灌注损伤或出血的组合物和方法
CN113995723B (zh) 2020-07-27 2025-02-18 浙江普洛家园药业有限公司 一种索法地尔冻干粉针剂的制备方法及其产品和用途
JP2025500716A (ja) * 2021-12-28 2025-01-14 ジーエヌティー ファーマ カンパニー， リミテッド 肺障害を処置するための組成物及び方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1551793B1 (en) * 2002-06-19 2016-01-20 AmKor Pharma, Inc. Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
KR100522188B1 (ko) * 2003-01-20 2005-10-18 주식회사 뉴로테크 뉴로트로핀에 의해 유도되는 세포괴사 억제 방법
WO2006126825A1 (en) 2005-05-23 2006-11-30 Choongwae Pharma Corporation Composition comprising tetrafluorobenzyl derivatives or salts of thereof for injection
EP1883619B8 (en) * 2005-05-25 2013-05-01 JW Pharmaceutical Corporation Process of preparation of substituted tetrafluorobenzylaniline compound and its pharmaceutically approved salts
KR101523345B1 (ko) * 2008-04-28 2015-05-28 주식회사 지엔티파마 재관류 손상의 치료 또는 예방용 약학 조성물
CN102617383A (zh) 2012-03-20 2012-08-01 横店集团家园化工有限公司 索法地尔晶型、制备方法及包含索法地尔晶体的无菌粉末
AU2016210973B2 (en) 2015-01-27 2019-02-14 Astrazeneca Ab Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction
CN115515573A (zh) 2020-03-11 2022-12-23 Gnt制药有限公司 用于治疗再通疗法之后再灌注损伤或出血的组合物和方法

Similar Documents

Publication Publication Date Title
JP2023517566A5 (https=)
KR101186029B1 (ko) 신경병증성 당뇨병성 족부 궤양을 치료하기 위한트레프로스티닐의 용도
JP5775246B2 (ja) 関節痛を治療する薬剤を生成するためのレシニフェラトキシン（ｒｔｘ）の使用方法および前記薬剤を適用する方法
US20220340650A1 (en) Combination therapy with cgrp antagonists
ES2237407T3 (es) Combinaciones para el tratamiento de enfermedades que implican angiogenesis.
JP2008524267A (ja) バニロイド受容体作用薬と神経再生物質阻害物質との混合物、鎮痛薬を生成するためのそれらの使用、および該鎮痛薬を適用する方法
ES2244625T3 (es) Uso de derivados de biguanida para la fabricacion de un medicamento con efecto cicatrizante.
US11826329B2 (en) Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy
JP5080983B2 (ja) バニロイド受容体アゴニストをグリコースアミノグリカンまたはプロテオグリカンとともに関節痛治療のための薬剤の製造に用いることおよび前記薬剤の適用方法
KR100701539B1 (ko) 멜라가트란의 신규 용도
Lawrence Drug management in skin surgery
CN108697673A (zh) 用于治疗莫顿神经瘤疼痛的辣椒碱依次给予方法
JP3502574B2 (ja) 眼感染症治療用眼軟膏剤
JP2003160509A (ja) 乳癌の治療
Mammdoh et al. Evaluation of anti-inflammatory effect of topical Serratiopeptidase in mice
JPH07506333A (ja) 勃起機能不全症治療用ピリジルグアニジン化合物
US20230414617A1 (en) Pharmaceutical composition comprising acid-base neutralization combination and application thereof
US20190365730A1 (en) Anaesthetic composition comprising ropivacaine, prilocaine and lidocaine
JP2000507207A (ja) 複合注射剤
CA2785303A1 (en) Method for the non-surgical treatment of lipodystrophy in a retrovirus-infected individual
SK51298A3 (en) Pharmaceutical compositions containing platelet aggregation inhibitors
JP2024525239A (ja) 化合物ｓｍｔｐ－７を含有する医薬組成物
Shaub ISCHEMIC NECROSIS DUE TO ADMINISTRATION OF METARAMINOL: REPORT OF A CASE
BR122025026201A2 (pt) Composições que compreendem o composto derivado de tetrafluorobenzila, frascos compreendendo as mesmas, uso terapêutico das mesmas e método para preparar o referido composto
WO2001097812A1 (fr) Preparations pharmaceutiques contenant des composes tetracycliques